Navigation Links
Dynatronics Announces First Quarter Financial Results
Date:11/14/2013

They will augment our geographical reach to practitioners across the country. The addition of these new reps brings us nearly halfway to our goal of adding 75 new sales representatives selling our products."

"We've also developed a major new product that we expect to introduce in the quarter ending December 31, 2013," reported Larry K. Beardall, executive vice president of sales and marketing. "This is the Dynatron Thermostim Probe™, and will be one of the most innovative and attractive products in our history. The Thermostim Probe is a soft-tissue mobilization tool that also allows a practitioner to deliver heat or cold therapy in combination with electrical stimulation – all at the same time."The new hand-held probe is an accessory to the Dynatron SolarisPlus family of products. It utilizes a thermoelectric chip to generate the thermal therapy and is powered by any one of four Dynatron SolarisPlus units.

"Demand for this innovative probe is building even before it is released," stated Beardall. "We now have indications of interest from over 500 clinicians across the country who have become aware of this innovative new product. And since the probe is operated from the control console of the SolarisPlus units, we expect demand for SolarisPlus units to rise commensurate with the demand for the ThermoStim probe."

"We believe the introduction of the new Thermostim probe, together with the expansion of our distribution channel, will be the impetus to return Dynatronics to profitability," Cullimore concluded.

Dynatronics has scheduled a conference call for investors today, Thursday, November 14, 2013, at 12:30 p.m. ET. Those wishing to participate should call (800) 954-0586.

The following is a summary of the financial results as of September 30, 2013 and 2012, and for the quarter then ended:  Summary Selected Financial DataStatement of Operations HighlightsThree Months Ended
September
'/>"/>

SOURCE Dynatronics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dynatronics To Release Fiscal First Quarter Results Thursday, November 14, 2013;
2. Dynatronics Announced Changes in Todays Conference Call Monday, September 30, 2013; Conference Call set for 4:30 p.m. ET
3. Dynatronics Announces Year-End Financial Results
4. Dynatronics To Release Fiscal 2013 Year-end Results Monday, September 30, 2013; Conference Call set for 3:30 p.m. ET
5. Dynatronics Appoints R. Scott Ward, PT PhD to its Board of Directors
6. Dynatronics Announces Third Quarter Results
7. Dynatronics To Release Fiscal Third Quarter Results Tuesday, May 14, 2013; Conference Call set for 1:30 p.m. ET
8. Dynatronics Second Quarter Profits Jump 204%
9. Dynatronics To Release Fiscal Second Quarter Results Wednesday, February 13, 2013; Conference Call set for 3:00 p.m. ET
10. Dynatronics Announces First Quarter Results
11. Dynatronics To Release Fiscal First Quarter Results Wednesday, November 14, 2012; Conference Call set for 4:30 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  BioLife Solutions, Inc. (NASDAQ: BLFS ), a ... hypothermic storage and cryopreservation freeze media and ... ("BioLife" or the "Company"), announced that the Company is scheduled ... The Company is scheduled to present at the Conference ... the Grand Hyatt Hotel in New York City ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... protection, repair and regeneration, today announced that J.J. ... to present a corporate overview at two upcoming investor ... the SeeThruEquity 4 th Annual Microcap Conference on ... City at 11:00 am EDT.  A webcast ...
(Date:5/22/2015)... , May 22, 2015 According ... Market by Product (Consumables, Instruments, Services), by Test Type ... Chromatography, Flow Cytometry), by End Users - Global Forecast ... Market is expected to reach $736.85 Million by 2020 ... of 10.25%. Browse 71 market data ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4
... BOULDER, Colo. and MONTREAL, Feb. 14 Pharmion,Corporation ... MYG) today announced,that the U.S. Food and Drug ... inhibitor, MGCD0103, as an Orphan,Drug for the treatment ... Criteria for designation require that the product be ...
... Australia, Feb. 13 Progen,Pharmaceuticals Limited (ASX: ... results from a phase 2 investigator-initiated trial ... Taxotere(R),(docetaxel) administered to patients with prostate cancer. ... Haematology and Oncology Clinics, the,principal investigator conducting ...
Cached Medicine Technology:Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 3Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 4Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium 2Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium 3
(Date:5/22/2015)... The dentist in West ... they are now offering complimentary consultations to patients ... At consultations, patients can discuss their candidacy for ... treatments can achieve and whether alternative options are ... appointment. If treatments are chosen, patients can start ...
(Date:5/22/2015)... May 22, 2015 sweetFrog Enterprises, LLC. is ... Jacksonville, Texas. Jacksonville is now the 16th sweetFrog store located ... was listed as #22 on the Inc. 500 list of ... lived and worked in East Texas for 20 years and ... owner of the Jacksonville, and nearby Palestine, sweetFrog locations. “We ...
(Date:5/22/2015)... DMG Productions announces the upcoming airing of Innovations ... May 29, 2015 at 7:30 a.m. ET and 7:30 ... Innovations will explore Interstate Restoration, a company dedicated to ... recovery and restoration. , Additionally, the series will focus ... and deliver training and education in the areas of ...
(Date:5/22/2015)... York, NY (PRWEB) May 22, 2015 ... Multifamily Housing, Marc Zuluaga, has been selected by Consulting-Specifying ... engineering. The award winners are featured in the May/June ... to 40 building industry professionals age 40 and younger ... the building community, as well as in other areas ...
(Date:5/22/2015)... A new program for the "In America" ... of Physical Therapy. , James Earl Jones will ... of physical therapy and discusses how the exercises can ... variety of ailments and injuries. Physical therapists work ... that enhances daily activities such as house cleaning and ...
Breaking Medicine News(10 mins):Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2
... 2 Mylan Inc. (NYSE: MYL ),today announced ... Asia Pacific following the completion of Mylan,s acquisition of,Merck,s ... over 30 years in the pharmaceuticals,industry and has extensive ... UK, U.S. and Asia Pacific regions. At Merck,Generics, he ...
... Mylan Inc. (NYSE: MYL ),today announced the ... (Europe, Middle East and Africa) following the completion,of Mylan,s ... Generics, M. Barret most recently served as Region Director,EMEA, ... position in 2004,following his role as Area Director for ...
... in obstetrics and ... emergency departments., CHICAGO, Oct. 2 ... according to the Aon Corporation 2007,Hospital Professional Liability and Physician Liability ... liability,claims in the U.S. health care industry, is published by Aon ...
... One recommendation: MRIs, other scans aren,t always helpful , TUESDAY, ... order MRIs, CT scans and other diagnostic tests for patients ... released by the American College of Physicians and the American ... Oct. 2 issue of the journal Annals of Internal ...
... effects impacting cognition don,t end with the last dose ... cognitive impairment experienced by 14 to 45 percent of ... personal and professional lives. Patients report that the lack ... and the inability to organize or multi-task have led ...
... Holding, Inc. (OTCBB: MITD - News), has signed an ... stop the spread of infectious diseases. Dr. Thomas ... Director of the Biodefense and Infectious Disease Laboratory and ... of Public Health, Georgia Southern University, will oversee the ...
Cached Medicine News:Health News:Mylan Announces Appointment of John Montgomery as President, Asia Pacific 2Health News:Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa 2Health News:Aon Corporation Study Finds Hospital Claims at New Lows 2Health News:Aon Corporation Study Finds Hospital Claims at New Lows 3Health News:Aon Corporation Study Finds Hospital Claims at New Lows 4Health News:Aon Corporation Study Finds Hospital Claims at New Lows 5Health News:Experts Issue Guidelines on Treating Low Back Pain 2Health News:Cognitive deficits lead to 'loss of self' among cancer patients 2
Used in conjunction with the E5381 700 Circling Band (240 style). Indications: When high buckle is required. Overall length: 11.6 mm....
Asymmetrical concave inner surface to conform to globe. Used in conjunction with the E5381 700 Circling Band (240 style). Indications: Wide scleral bed. Outside diameter 31.7 mm....
Concave inner surface to conform to the globe. Used in conjunction with the E5381 600 Circling Band (240 style). Indications: Wide scleral bed. Outside diameter 31.7 mm....
Used in conjunction with the E5381 700 Circling Band (240 style). Indications: Narrow scleral bed. Overall length: 100 mm, 3.9 inches....
Medicine Products: